Please find correspondence (LETTER and BULLETIN) from Kathryn Turner, Pharmacy Lead, HSCB.
SUMMARY
The Medicines Use Review (MUR) Service was introduced in 2013, since then over 185,000 MURs have been undertaken in our community pharmacies.
The School of Pharmacy and Pharmaceutical Sciences, Ulster University, Coleraine evaluated the service, and the report can be found HERE.
The service will not be commissioned in the same format moving forward. However, a pathfinder medicine discharge service pilot will be established in the North-West of the province in the autumn of this year in advance of planned roll-out across all pharmacies on 2022/23.
ACTION
Contractors are asked to review the correspondence.
For further queries please contact your local pharmacy adviser or CPNI.
Kind regards
SENT ON BEHALF OF GERARD GREENE Chief Executive
This update contains important information for community pharmacy teams, including details of the ongoing response to the COVID-19 pandemic.
SENT ON BEHALF OF DR. GARETH C. GILVARY Governance & Support Pharmacist
Dear Colleague
The following concessionary prices have been granted for July 2021:
Drug
Pack Size
Concessionary Price
Baclofen 10mg tablets
84
£3.30
Loratadine 5mg/5ml oral solution
100ml
£7.75
Mebeverine 135mg tablets
100
£4.40
Pregabalin 100mg capsules
84
£5.42
Tolbutamide 500mg tablets
28
£16.79
Trimethoprim 50mg/5ml oral suspension sugar free
100ml
£11.94
Ursodeoxycholic acid 250mg capsules
60
£11.98
This is the second update of concessionary prices for July 2021.
Concessionary prices will be paid against the usual code, no additional endorsements are needed.
Concessionary prices may be granted up until the end of the month so CPNI will notify you of any further concessionary prices as and when they are agreed.
Please continue to notify CPNI of any pricing issues you are experiencing via our new Medicine Shortage Reporter.
Concessionary prices are also published on the CPNI website.
Kind regards
SENT ON BEHALF OF DR. GARETH C. GILVARY Governance & Support Pharmacist
Dear Colleague
The following concessionary prices have been granted for July 2021:
Drug
Pack Size
Concessionary Price
Eplerenone 25mg tablets
28
£11.95
Eplerenone 50mg tablets
28
£15.53
Etoricoxib 60mg tablets
28
£6.00
Etoricoxib 90mg tablets
28
£8.35
Naftidrofuryl 100mg capsules
84
£7.84
Olmesartan medoxomil 20mg tablets
28
£6.44
Olmesartan medoxomil 40mg tablets
28
£10.35
Pregabalin 75mg capsules
56
£4.18
Sodium fluoride 0.05% mouthwash sugar free
250ml
£1.74
Sulfasalazine 500mg gastro-resistant tablets
112
£17.52
Sulfasalazine 500mg tablets
112
£16.50
This is the first update of concessionary prices for July 2021.
Concessionary prices will be paid against the usual code, no additional endorsements are needed.
Concessionary prices may be granted up until the end of the month so CPNI will notify you of any further concessionary prices as and when they are agreed.
Please continue to notify CPNI of any pricing issues you are experiencing via our new Medicine Shortage Reporter.
SENT ON BEHALF OF DR. GARETH C. GILVARY Governance & Support Pharmacist
Dear Colleague
Please find correspondence HERE for the attention of all Community Pharmacies offering Living Well service, from HSCB Pharmacy & Medicines Management.
SUMMARY
The last campaign of 2020/2021, How are you feeling?, finished on 31 May 2021.
Pharmacies offering Living Well are required to complete an online evaluation survey for this campaign.
It is vital that all pharmacies contracted to provide “Living Well” submit their evaluation survey as it allows HSCB to collate data to demonstrate the value and impact of the service to other sectors. Additionally, it supports future commissioning and service development.
The HSCB monitors compliance with the service requirements, in particular evaluation submission. Should your pharmacy fail to submit an evaluation survey response, the HSCB reserves the right to recover all, or part of, this funding via an adjustment to the pharmacy’s BSO payment account.
ACTION
Contractors are asked to review the correspondence.
Pharmacies offering Living Well service are required to complete an evaluation survey, available HERE by 19 July 2021.
If you have already completed this, you do not need to do anything further.
Kind regards
SENT ON BEHALF OF DR. GARETH C. GILVARY Governance & Support Pharmacist
WhatsApp Business Terms of Service can be found here and privacy policy hereUCA-NI Privacy Policy We take your privacy seriously and do not share or sell any personal details with third parties for commercial purposes. If you have any questions, please contact the CPNI office. You can withdraw your consent to be contacted at any time by calling 028 9069 0444 or by emailing info@communitypharmacyni.co.uk. CPNI Data Protection Policy and Data Retention policy can be found Click Here
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking “Accept”, you consent to the use of ALL the cookies.
This website uses cookies to improve your experience while you navigate through the website. Out of these cookies, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may have an effect on your browsing experience.
Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.
Any cookies that may not be particularly necessary for the website to function and is used specifically to collect user personal data via analytics, ads, other embedded contents are termed as non-necessary cookies. It is mandatory to procure user consent prior to running these cookies on your website.